Resmed Inc. buy KeyCorp
Start price
31.01.25
/
50%
€232.00
Target price
31.01.26
€269.28
Performance (%)
-7.63%
End price
01.02.26
€214.30
Summary
This prediction ended on 01.02.26 with a price of €214.30. With a performance of -7.63%, the BUY prediction by KeyCorp finished with a loss. KeyCorp has a follow-up prediction for Resmed Inc. where he still thinks Resmed Inc. is a Buy. Dividends of €0.51 are taken into consideration when calculating the performance. KeyCorp has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Resmed Inc. | 7.264% | 7.264% | -25.525% |
| iShares Core DAX® | 3.901% | 2.667% | 5.690% |
| iShares Nasdaq 100 | -2.603% | -7.934% | 19.505% |
| iShares Nikkei 225® | -0.545% | -9.754% | 46.053% |
| iShares S&P 500 | -0.881% | -1.488% | 16.911% |
Comments by KeyCorp for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) had its price target raised by analysts at KeyCorp from $266.00 to $280.00. They now have an "overweight" rating on the stock.
Ratings data for RMD provided by MarketBeat
In the thread Trading Resmed Inc.
Die von KeyCorp gewählte maximale Laufzeit wurde überschritten